Prevalence and functional consequences of severe insomnia symptoms in mood and anxiety disorders: Results from a nationally representative sample

Sleep

Volumn 35, Issue 10, 2012, Pages 1367-1375

  Soehner, Adriane M ^a   Harvey, Allison G ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anxiety disorders; Insomnia; Mood disorders

Indexed keywords

ADULT; AGED; ANXIETY DISORDER; ARTICLE; COGNITION; COMORBIDITY; CONTROLLED STUDY; DISABILITY; DISEASE SEVERITY; DSM-IV; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEALTH SURVEY; HUMAN; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PATIENT MOBILITY; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; SELF CARE; SOCIAL INTERACTION; WORLD HEALTH ORGANIZATION COMPOSITE INTERNATIONAL DIAGNOSTIC INTERVIEW; WORLD HEALTH ORGANIZATION DISABILITY ASSESSMENT SCHEDULE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; AGED; ANXIETY DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; MALE; MIDDLE AGED; MOOD DISORDERS; PREVALENCE; SLEEP INITIATION AND MAINTENANCE DISORDERS; UNITED STATES; YOUNG ADULT;

EID: 84867035375     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2116     Document Type: Article

References (58)

1. Robins LN, Locke BZ, Regier DA. An overview of psychiatric disorders in America. In: Robins LN, Regier DA, eds. Psychiatric disorders in America: the epidemiologic catchment area study. New York, NY: Free Press; 1991:328-66.
2. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19. (Pubitemid 24028993)
3. Regier DA, Rae DS, Narrow WE, Kaelber CT, Schatzberg AF. Prevalence of anxiety disorders and their comorbidity with mood and addictive disorders. Br J Psychiatry Suppl 1998;34:24-8. (Pubitemid 28312194)
4. Zimmerman M, Chelminski I, McDermut W. Major depressive disorder and axis I diagnostic comorbidity. J Clin Psychiatry 2002;63:187-93. (Pubitemid 34407076)
5. Kessler RC, Berglund P, Demler O, et al. The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA 2003;289:3095-105. (Pubitemid 37432885)
6. Krishnan KR. Psychiatric and medical comorbidities in bipolar disorder. Psychosomatic Med 2005;67:1-8.
7. Lamers F, van Oppen P, Comjis HC, et al. Comorbidity patterns of anxiety and depressive disorders in a large cohort study: the Netherlands Study of Depression and Anxiety (NESDA). J Clin Psychiatry 2011;72:341-8.
8. Belzer K, Schneier FR. Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment. J Psychiatr Pract 2004;10:296-306. (Pubitemid 39299042)
9. Emmanuel J, Simonds D, Tyrer P. Systematic review of the outcome of anxiety and depressive disorders. Br J Psychiatry Suppl 1998;34:35-41. (Pubitemid 28312196)
10. Goldenberg IM, White K, Yonkers K, et al. The infrequency of "pure culture" diagnoses among the anxiety disorders. J Clin Psychiatry 1996;57:528-33. (Pubitemid 26412505)
11. McDermut W, Mattia J, Zimmerman M. Comorbidity burden and its impact on psychosocial morbidity in depressed outpatients. J Affec Disord 2001;65:289-95. (Pubitemid 32757160)
12. Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med Rev 2002;6:97-111. (Pubitemid 35231066)
13. Van Mill JG, Hoogendijk WJ, Vogelzangs N, van Dyck R, Penninx BW. Insomnia and sleep duration in a large cohort of patients with major depressive disorder and anxiety disorders. J Clin Psychiatry 2010;71:239-46.
14. Sunderjan P, Gaynes BN, Wisiewski SR, et al. Insomnia in patients with depression: A STAR*D Report. CNS Drugs 2010;15:394-404.
15. Uhde TW, Cortese BM, Vedeniapin A. Anxiety and sleep problems: emerging concepts and theoretical treatment implications. Curr Psychiatry Rep 2009;11:269-76.
16. Harvey AG, Schmidt DA, Scarna A, Semler CN, Goodwin GM. Sleep-related functioning in euthymic patients with bipolar disorder, patients with insomnia and subjects without sleep problems. Am J Psychiatry 2005;162:50-7. (Pubitemid 40095672)
17. Roth T, Jaeger S, Jin R, et al. Sleep problems, comorbid mental disorders and role functioning in the National Comorbidity Survey-Replication (NCS-R). Biol Psychiatry 2006;60:1364-71. (Pubitemid 44838536)
18. Ohayon MM, Roth T. Place of insomnia in the course of depressive and anxiety disorders. J Psychiatr Res 2003;27:9-15. (Pubitemid 35449766)
19. Merikangas KR, Akiskal HS, Angst J, et al. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication. Arch Gen Psychiatry 2007;64:543-52. (Pubitemid 46718287)
20. Rhebergen D, Beekman AT, Graaf R, et al. The three-year naturalistic course of major depressive disorder, dysthymic disorder and double depression. J Affect Disord 2009;115:450-9.
21. Baglioni C, Battagliese G, Fiege B, et al. Insomnia as a predictor of depression: a meta-analytic evaluation of epidemiological studies. J Affect Disord 2011;135:10-19.
22. McCall WV. A psychiatric perspective on insomnia. J Clin Psychiatry 2001;24:451-66.
23. Stein MB, Belik SL, Jacobi F, Sareen J. Impairment associated with sleep problems in the community: relationship to physical and mental health comorbidity. Psychosom Med 2008;70:913-9.
24. Carney CE, Segal ZV, Edinger JD, Krystal AD. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J Clin Psychiatry 2007;68:254-60. (Pubitemid 46362647)
25. Hauri P, Chernik D, Hawkins D, Mendels J. Sleep of depressed patients in remission. Arch Gen Psychiatry 1974;31:386-91.
26. Nierenberg AA, Keefe BR, Leslie VC, et al. Residual symptoms in depressed patients who respond acutely to fluoxetine. J Clin Psychiatry 1999;60:221-5. (Pubitemid 29193918)
27. Cervena K, Matousek M, Prasko J, Brunovsky M, Paskova B. Sleep disturbances in patients treated for panic disorder. Sleep Med 2005;6:149-53. (Pubitemid 40247177)
28. Zayfert C, DeViva JC. Residual insomnia following cognitive behavioral therapy for PTSD. J Trauma Stress 2004;17:69-73. (Pubitemid 38280767)
29. Perlis ML, Giles DE, Buysse DJ, Tu X, Kupfer DJ. Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 1997;42:209-12. (Pubitemid 27170166)
30. Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep 2007;30:873-80. (Pubitemid 47041390)
31. Johnson EO, Roth T, Beslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J Psychiatr Res 2006;40:700-8. (Pubitemid 44486249)
32. Bolge SC, Joish VN, Balkrishnan R, Kannan H, Drake CL. Burden of chronic sleep maintenance insomnia characterized by nighttime awakenings among anxiety and depression sufferers: results of a national survey. Prim Care Companion J Clin Psychiatry 2010;12:e1-7.
33. Ramsawh HJ, Stein MB, Belik SL, Jacobi F, Sareen J. Relationship of anxiety disorders, sleep quality, and functional impairment in a community sample. J Psychiatr Res 2009;43:926-33.
34. Gureje O, Makanjuola VA, Kola L. Insomnia and role impairment in the community: results from the Nigerian survey of mental health and well-being. Soc Psychiatry Psychiatr Epidemiol 2007;42:495-501. (Pubitemid 46887822)
35. Kessler RC, Merikangas KR. The National Comorbidity Survey Replication (NCS-R): background and aims. Int J Methods Psychiatr Res 2004;13:60-8. (Pubitemid 39199021)
36. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey. Arch Gen Psychiatry 1994;51:8-19. (Pubitemid 24028993)
37. Kessler RC, Ustün TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res 2004;13:93-121.
38. Schoenborn CA, Adams PF, Schiller JS. Summary health statistics for the U.S. population: National Health Interview Survey, 2000. Vital and Health Statistics 2003;10:1-83.
39. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th edition, text revision). Washington, D.C.: American Psychiatric Association, 2000.
40. American Academy of Sleep Medicine. International classification of sleep disorders, 2nd edition: diagnostic and coding manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
41. Chwastiak LA, Von Korff M. Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO DAS II) in a primary care setting. J Clin Epidemiol 2003;56:507-14. (Pubitemid 36842907)
42. Lee M, Choh AC, Demerath EW, et al. Sleep disturbance in relation to health-related quality of life in adults: the Fels Longitudinal Study. J Nutr Health Aging 2009;13:576-83.
43. Insel T, Cuthbert B, Garvey M, et al. Research domain criteria (RDoC): toward a new classification framework for research on mental disorders. Am J Psychiatry 2010;167:748-51.
44. Harvey AG, Watkins E, Mandsell W, Shafran R. Cognitive behavioural processes across psychological disorders: a transdiagnostic approach to research and treatment. Oxford, UK: Oxford University Press, 2004.
45. Kohn L, Espie CA. Sensitivity and specificity of measures of the insomnia experience: a comparative study of psychophysiologic insomnia, insomnia associated with mental disorder and good sleepers. Sleep 2005;28:104-12. (Pubitemid 40543125)
46. Benca RM, Peterson MJ. Insomnia and depression. Sleep Med 2008;9:S3-9.
47. Brown TA, Barlow DH, Chorpita BF. Structural relationships among dimensions of the DSM-IV anxiety and mood disorders and dimensions of negative affect, positive affect and autonomic arousal. J Abnorm Psychol 1998;107:179-92. (Pubitemid 28237482)
48. Sachs GS, Thase ME, Otto MW, Bauer M, Miklowitz D, Wisniewski SR, et al. Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biological Psychiatry 2003;53:1028-42. (Pubitemid 36645233)
49. Angst J, Gamma A, Clarke D, Ajdacic-Gross V, Rössler W, Regier D. Subjective distress predicts treatment seeking for depression, bipolar, anxiety, panic, neurasthenia and insomnia severity spectra. Acta Psychiatr Scand 2010;122:488-98.
50. Edinger JD, Olsen MK, Stechuchak KM, et al. Cognitive behavioral therapy for patients with primary insomnia or insomnia associated predominantly with mixed psychiatric disorders: a randomized clinical trial. Sleep 2009;32:499-510.
51. Manber R, Edinger JD, Gress JL, San Pedro-Salcedo MG, Kuo TF, Kalista T. Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep 2008;31:489-95.
52. DeViva JC, Zayfert C, Pigeon WR, Mellman TA. Treatment of residual insomnia after CBT for PTSD: case studies. J Trauma Stress 2005;18:155-9. (Pubitemid 46422006)
53. Fava M, McCall WV, Krystal A, et al. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder. Biol Psychiatry 2006;59:1052-60. (Pubitemid 43849658)
54. Fava M, Asnis GM, Shrivstava et al. Improved insomnia symptoms and sleep-related next day functioning in patients with comorbid major depressive disorder and insomnia following concomitant zolpidem extended-release 12.5 and escitalopram treatment: A randomized controlled trial. J Clin Psychiatry 2011;72:914-28.
55. Fava M, Schaefer K, Huang H, et al. A post hoc analysis of the effect of nightly administration of eszopiclone and a selective serotonin reuptake inhibitor in patients with insomnia and anxious depression. J Clin Psychiatry 2011;72:473-9.
56. Pollack M, Kinrys G, Krystal A, et al. Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. Arch Gen Psychiatry 2008;65:551-62. (Pubitemid 351645051)
57. Pollack M, Hoge E, Worthington JJ, et al. Eszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial. J Clin Psychiatry 2011;72; 892-7.
58. Schaffer CB, Schaffer LC, Miller AR, Hang E, Nordahl TW. Efficacy and safety of nonbenzodiazepine hypnotics for chronic insomnia in patients with bipolar disorder. J Affect Disord 2011;128:305-8.